why choose us

First received: October 05, 2022

Clinical Trial: A Study of SGN-BB228 in Advanced Melanoma and Other Solid Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cutaneous Melanoma

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Study of SGN-BB228 in Advanced Melanoma and Other Solid Tumors

Brief Summary: This study will test the safety of a drug called SGN-BB228 in participants with melanoma and other solid tumors that are hard to treat or have spread through the body.It will also study the side effects of this drug.A side effect is anything a drug does to the body besides treating the disease.This study will have 3 parts.Parts A and B of the study will find out how much SGN-BB228 should be given to participants.Part C will use the information from Parts A and B to see if SGN-BB228 is safe and if it works to treat…

Read more